Literature DB >> 9184586

Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model.

K Ono1, A Matsumori, T Shioi, Y Furukawa, S Sasayama.   

Abstract

BACKGROUND: Hepatocyte growth factor (HGF) is a multifunctional factor implicated in tissue regeneration, wound healing, and angiogenesis. Circulating HGF is reportedly elevated during the early stage of myocardial infarction. However, its precise effect on the heart is unknown. To evaluate the regulation of HGF in ischemically damaged myocardium, the production of HGF and its high-affinity receptor, c-Met, was studied in a rat model of myocardial ischemia and reperfusion. METHODS AND
RESULTS: The plasma concentration of HGF began to increase within 1 hour of reperfusion after 1 hour of ischemia. The peak level was reached at 3 hours after reperfusion. Northern blotting revealed that HGF mRNA expression in the heart was augmented threefold at 24 and 48 hours and remained elevated by twofold at 120 hours after the myocardium was reperfused. The signal for c-met, high-affinity HGF receptor mRNA, was also upregulated parallel to upregulation for HGF. In the kidney, liver, lung, and spleen, HGF mRNA was also maximally increased at 12 hours after reperfusion. However, c-met was not upregulated in these organs. Immunohistochemical studies disclosed that capillary endothelial and interstitial cells, including infiltrating macrophages, were intensely stained for HGF, whereas capillary endothelial cells in the reperfused myocardium were positive for c-Met.
CONCLUSIONS: This study is the first to show that myocardial ischemia and reperfusion induced HGF expression in various organs in vivo. These results indicate that HGF/c-Met plays a role in capillary endothelial cell regeneration in the ischemically injured heart.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9184586     DOI: 10.1161/01.cir.95.11.2552

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  48 in total

Review 1.  Targeting angiogenesis to restore the microcirculation after reperfused MI.

Authors:  Anja M van der Laan; Jan J Piek; Niels van Royen
Journal:  Nat Rev Cardiol       Date:  2009-06-16       Impact factor: 32.419

2.  Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.

Authors:  Sebastian Vogel; Madhumita Chatterjee; Katja Metzger; Oliver Borst; Tobias Geisler; Peter Seizer; Iris Müller; Andreas Mack; Susanne Schumann; Hans-Jörg Bühring; Florian Lang; Rüdiger V Sorg; Harald Langer; Meinrad Gawaz
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

Review 3.  Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern?

Authors:  Xuyang Peng; Laura Pentassuglia; Douglas B Sawyer
Journal:  Circ Res       Date:  2010-04-02       Impact factor: 17.367

4.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

Review 5.  Cardiac progenitor cells and bone marrow-derived very small embryonic-like stem cells for cardiac repair after myocardial infarction.

Authors:  Xian-Liang Tang; D Gregg Rokosh; Yiru Guo; Roberto Bolli
Journal:  Circ J       Date:  2010-01-18       Impact factor: 2.993

Review 6.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

7.  Hepatocyte growth factor-mediated attraction of mesenchymal stem cells for apoptotic neuronal and cardiomyocytic cells.

Authors:  Sebastian Vogel; Thorsten Trapp; Verena Börger; Corinna Peters; Dalila Lakbir; Dagmar Dilloo; Rüdiger V Sorg
Journal:  Cell Mol Life Sci       Date:  2009-11-03       Impact factor: 9.261

8.  Utility of Hepatocyte Growth Factor as a Biomarker for Early Diagnosis of Pulmonary Artery Hypertension.

Authors:  Mingting Liang; Ying Pang; Shuguang Zhang; Mei Zhang
Journal:  Mol Diagn Ther       Date:  2016-10       Impact factor: 4.074

9.  Hepatocyte growth factor(HGF): a new biochemical marker for acute myocardial infarction.

Authors:  T Sato; T Yoshinouchi; T Sakamoto; H Fujieda; S Murao; H Sato; H Kobayashi; T Ohe
Journal:  Heart Vessels       Date:  1997       Impact factor: 2.037

10.  Hepatocyte growth factor regulates angiotensin converting enzyme expression.

Authors:  Regina M Day; Gerald Thiel; Julie Lum; Rubén D Chévere; Yongzhen Yang; Joanne Stevens; Laura Sibert; Barry L Fanburg
Journal:  J Biol Chem       Date:  2003-12-16       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.